Banque Pictet & Cie’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-3,257
| Closed | -$225K | – | 404 |
|
|
2025
Q2 | $225K | Buy |
3,257
+51
| +2% | +$3.34K | ﹤0.01% | 349 |
|
|
2025
Q1 | $217K | Buy |
+3,206
| New | +$192K | ﹤0.01% | 377 |
|
|
2023
Q3 | – | Sell |
-15,633
| Closed | -$1.08M | – | 455 |
|
|
2023
Q2 | $1.08M | Sell |
15,633
-258
| -2% | -$18.4K | 0.01% | 324 |
|
|
2023
Q1 | $1.18M | Buy |
+15,891
| New | +$1.33M | 0.01% | 351 |
|
|
2022
Q4 | – | Sell |
-17,600
| Closed | -$1.68M | – | 617 |
|
|
2022
Q3 | $1.68M | Buy |
+17,600
| New | +$1.74M | 0.02% | 315 |
|
|
2022
Q1 | – | Sell |
-21,736
| Closed | -$2.24M | – | 629 |
|
|
2021
Q4 | $2.24M | Buy |
21,736
+13,121
| +152% | +$1.21M | 0.02% | 323 |
|
|
2021
Q3 | $731K | Hold |
8,615
| – | – | 0.01% | 278 |
|
|
2021
Q2 | $719K | Hold |
8,615
| – | – | 0.01% | 281 |
|
|
2021
Q1 | $648K | Sell |
8,615
-10,000
| -54% | -$728K | 0.01% | 282 |
|
|
2020
Q4 | $1.27M | Sell |
18,615
-1,705
| -8% | -$111K | 0.02% | 214 |
|
|
2020
Q3 | $1.19M | Hold |
20,320
| – | – | 0.02% | 210 |
|
|
2020
Q2 | $1.32M | Hold |
20,320
| – | – | 0.02% | 206 |
|
|
2020
Q1 | $1.21M | Sell |
20,320
-2,250
| -10% | -$150K | 0.02% | 207 |
|
|
2019
Q4 | $1.68M | Buy |
22,570
+2,120
| +10% | +$149K | 0.03% | 209 |
|
|
2019
Q3 | $1.29M | Buy |
20,450
+8,108
| +66% | +$480K | 0.02% | 206 |
|
|
2019
Q2 | $673K | Sell |
12,342
-400
| -3% | -$21.5K | 0.01% | 239 |
|
|
2019
Q1 | $687K | Sell |
12,742
-9,291
| -42% | -$573K | 0.01% | 239 |
|
|
2018
Q4 | $1.44M | Buy |
22,033
+18,581
| +538% | +$1.39M | 0.03% | 197 |
|
|
2018
Q3 | $272K | Hold |
3,452
| – | – | 0.01% | 334 |
|
|
2018
Q2 | $222K | Sell |
3,452
-5,950
| -63% | -$392K | ﹤0.01% | 335 |
|
|
2018
Q1 | $585K | Sell |
9,402
-18,645
| -66% | -$1.34M | 0.01% | 271 |
|
|
2017
Q4 | $2.03M | Sell |
28,047
-115,028
| -80% | -$8.36M | 0.04% | 202 |
|
|
2017
Q3 | $11.6M | Sell |
143,075
-4,565
| -3% | -$361K | 0.26% | 70 |
|
|
2017
Q2 | $11.9M | Buy |
147,640
+18,187
| +14% | +$1.44M | 0.28% | 64 |
|
|
2017
Q1 | $10.2M | Sell |
129,453
-185,007
| -59% | -$14.8M | 0.25% | 74 |
|
|
2016
Q4 | $24.8M | Sell |
314,460
-29,216
| -9% | -$2.36M | 0.64% | 42 |
|
|
2016
Q3 | $30.6M | Sell |
343,676
-57,725
| -14% | -$5.45M | 0.79% | 35 |
|
|
2016
Q2 | $38.4M | Sell |
401,401
-123,230
| -23% | -$12.3M | 1.03% | 30 |
|
|
2016
Q1 | $54.4M | Buy |
524,631
+28,300
| +6% | +$2.75M | 1.42% | 26 |
|
|
2015
Q4 | $48.5M | Sell |
496,331
-34,040
| -6% | -$3.33M | 1.31% | 26 |
|
|
2015
Q3 | $51.2M | Buy |
+530,371
| New | +$55.8M | 1.53% | 18 |
|
|
2015
Q2 | – | Sell |
-450,483
| Closed | -$46.5M | – | 354 |
|
|
2015
Q1 | $46.5M | Buy |
450,483
+40,829
| +10% | +$4.13M | 1.21% | 21 |
|
|
2014
Q4 | $39.5M | Buy |
409,654
+6,035
| +1% | +$532K | 1.04% | 27 |
|
|
2014
Q3 | $32.1M | Sell |
403,619
-24,093
| -6% | -$1.9M | 0.83% | 35 |
|
|
2014
Q2 | $32.2M | Buy |
427,712
+79,654
| +23% | +$6.02M | 0.81% | 32 |
|
|
2014
Q1 | $26.1M | Sell |
348,058
-16,152
| -4% | -$1.14M | 0.71% | 35 |
|
|
2013
Q4 | $26.1M | Buy |
+364,210
| New | +$23.4M | 0.77% | 34 |
|
Other funds holding CVS
Banque Pictet & Cie's CVS Position: Q3 2025 in Review
Banque Pictet & Cie sold out of CVS Health (CVS) in Q3 2025, closing a stake of 3,257 shares — an estimated $225K sold.
Banque Pictet & Cie first reported a position in CVS in Q4 2013 and held it in 37 quarters. The position peaked at $54.4M in Q1 2016. 1,834 funds tracked by Wall St. Rank hold CVS as of Q3 2025.
- Banque Pictet & Cie reported no remaining CVS Health position as of Q3 2025 after selling out during the quarter.
- Banque Pictet & Cie sold 3,257 CVS Health shares in Q3 2025, an estimated $225K.
- Banque Pictet & Cie first reported a position in CVS Health in Q4 2013 and held it in 37 quarters.
- Banque Pictet & Cie's CVS Health position peaked at $54.4M in Q1 2016.
- 1,834 funds tracked by Wall St. Rank held CVS Health as of Q3 2025.
Based on Banque Pictet & Cie's 13F filing for Q3 2025, filed 21 Oct 2025.